According to Precedence Research, the global gRNA market size is expected to grow from USD 708.92 million in 2025 to nearly ...
This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...
A research team led by professor Olivia Merkel, Chair of Drug Delivery at LMU and co-spokesperson of the Cluster for Nucleic ...
A research team led by professor Olivia Merkel, Chair of Drug Delivery at LMU and co-spokesperson of the Cluster for Nucleic ...
To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...
Yas Clinic – Khalifa City, in collaboration with the Abu Dhabi Stem Cells Centre (ADSCC) and Vertex Pharmaceuticals, has ...
The Minister noted that with the development and transfer of India's first indigenous CRISPR-based gene therapy, the nation is moving closer to fulfilling Prime Minister Narendra Modi's goal of ...
ToolGen (KOSDAQ: 199800; CEO Jong-sang Ryu), a leader in genome editing technology, announced that the United States Patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results